PRKCH Gene Cerebral Infarction Susceptibility to Genetic Test
Are you concerned about your risk of cerebral infarction? DNA Labs UAE offers the PRKCH Gene Cerebral Infarction Susceptibility Genetic Test to help you understand your genetic predisposition to this condition.
Test Details
The PRKCH gene encodes for a protein kinase C eta (PKC eta) enzyme, which plays a crucial role in various cellular processes, including cell growth, differentiation, and apoptosis. Mutations in the PRKCH gene have been linked to an increased risk of cerebral infarction, a type of stroke caused by blocked blood flow to the brain.
Our PRKCH Gene Cerebral Infarction Susceptibility Genetic Test utilizes next-generation sequencing (NGS) technology to analyze a large number of genes simultaneously. This advanced testing method allows us to identify mutations in the PRKCH gene that may increase your risk of cerebral infarction. Additionally, we can also detect mutations in other genes associated with an elevated risk of stroke or other cardiovascular diseases.
Test Components and Price
Test Name: PRKCH Gene Cerebral Infarction Susceptibility to Genetic Test
- Components: Blood or Extracted DNA or One drop Blood on FTA Card
- Price: 4400.0 AED
Sample Collection
You can provide a blood sample or extracted DNA for this genetic test. Alternatively, you can use one drop of blood on an FTA card.
Report Delivery
Once your sample is received, our laboratory will process the test and deliver the report within 3 to 4 weeks.
Pre-Test Information
Before undergoing the PRKCH Gene Cerebral Infarction Susceptibility Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by PRKCH Gene Cerebral Infarction Susceptibility.
Test Department and Doctor
Test Department: Genetics
Doctor: Neurologist
Diagnosis and Symptoms
Cerebral infarction, or ischemic stroke, occurs when blood flow to the brain is blocked, leading to brain cell damage. Symptoms may include sudden weakness or numbness in the face, arm, or leg, difficulty speaking or understanding speech, severe headache, dizziness, and loss of coordination.
Post-Test Recommendations
If a mutation is identified in the PRKCH gene through NGS genetic testing, individuals may be advised to take steps to reduce their risk of stroke. This may include maintaining a healthy lifestyle, managing blood pressure and cholesterol levels, and taking medication if necessary. Genetic counseling may also be recommended to help individuals understand the implications of their genetic test results and make informed decisions about their health.
Don’t wait to take control of your health. Contact DNA Labs UAE today to schedule your PRKCH Gene Cerebral Infarction Susceptibility Genetic Test.
Test Name | PRKCH Gene Cerebral infarction susceptibility to Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PRKCH Gene Cerebral infarction, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PRKCH Gene Cerebral infarction, susceptibility to |
Test Details | The PRKCH gene is a gene that encodes for a protein kinase C eta (PKC eta) enzyme. This enzyme is involved in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis. Mutations in the PRKCH gene have been associated with an increased risk of cerebral infarction, which is a type of stroke that occurs when blood flow to the brain is blocked. NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze a large number of genes simultaneously. This type of testing can be used to identify mutations in the PRKCH gene that may increase the risk of cerebral infarction. NGS genetic testing can also be used to identify mutations in other genes that may be associated with an increased risk of stroke or other cardiovascular diseases. If a mutation is identified in the PRKCH gene through NGS genetic testing, individuals may be advised to take steps to reduce their risk of stroke, such as maintaining a healthy lifestyle, managing blood pressure and cholesterol levels, and taking medication if necessary. In some cases, genetic counseling may also be recommended to help individuals understand the implications of their genetic test results and make informed decisions about their health. |